InVivo Therapeutics Holdings - 14 Year Stock Price History | NVIVQ

Historical daily share price chart and data for InVivo Therapeutics Holdings since 2010 adjusted for splits and dividends. The latest closing stock price for InVivo Therapeutics Holdings as of February 12, 2024 is 0.32.
  • The all-time high InVivo Therapeutics Holdings stock closing price was 425249.98 on July 22, 2013.
  • The InVivo Therapeutics Holdings 52-week high stock price is 1.23, which is 284.4% above the current share price.
  • The InVivo Therapeutics Holdings 52-week low stock price is 0.22, which is 31.3% below the current share price.
  • The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 0.81.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
InVivo Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.6440 0.7896 0.7900 0.2220 0.3207 -56.07%
2023 1.3134 2.2900 2.6300 0.6016 0.7300 -68.94%
2022 5.6725 13.2000 13.4725 1.7550 2.3500 -79.39%
2021 19.8499 20.3750 44.5000 11.4025 11.4025 -43.69%
2020 58.6882 157.5750 251.2500 13.1775 20.2500 -87.99%
2019 682.7608 1222.4999 1282.4999 99.2250 168.6750 -85.11%
2018 4855.6345 17062.4991 17062.4991 1049.9999 1132.4999 -92.16%
2017 47179.5021 77812.4961 92812.4954 14249.9993 14437.4993 -81.67%
2016 109862.3457 136312.4932 184687.4908 68624.9966 78749.9961 -41.67%
2015 202994.0375 97499.9951 333374.9833 97499.9951 134999.9933 36.36%
2014 100752.9712 167999.9916 194999.9903 37499.9981 98999.9951 -42.61%
2013 197354.1568 131249.9934 425249.9787 82499.9959 172499.9914 32.18%
2012 159725.9920 209249.9895 212999.9894 95999.9952 130499.9935 -36.73%
2011 90693.4479 146999.9927 232499.9884 44999.9978 206249.9897 22.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.001B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.664B 26.43
Stryker (SYK) United States $141.745B 33.12
Boston Scientific (BSX) United States $122.979B 37.45
Medtronic (MDT) Ireland $115.565B 17.20
EssilorLuxottica (ESLOY) France $106.116B 0.00
Haleon (HLN) United Kingdom $48.437B 35.40
Lonza Group Ag (LZAGY) Switzerland $47.258B 0.00
ResMed (RMD) United States $36.993B 32.57
Koninklijke Philips (PHG) Netherlands $29.119B 22.13
Terumo (TRUMY) Japan $27.757B 39.20
Zimmer Biomet Holdings (ZBH) United States $21.878B 13.77
Baxter (BAX) United States $20.540B 13.93
Insulet (PODD) United States $16.399B 68.99
Smith & Nephew SNATS (SNN) United Kingdom $13.775B 0.00
Bio-Rad Laboratories (BIO) United States $9.205B 30.50
Demant (WILYY) Denmark $9.197B 0.00
BellRing Brands (BRBR) United States $7.646B 32.33
Lantheus Holdings (LNTH) United States $7.464B 17.92
ICU Medical (ICUI) United States $4.385B 41.84
Haemonetics (HAE) United States $3.926B 19.42
TG Therapeutics (TGTX) United States $3.854B 40.80
Perrigo (PRGO) Ireland $3.848B 12.16
GN Store Nord (GNNDY) Denmark $3.656B 22.03
Prestige Consumer Healthcare (PBH) United States $3.651B 18.19
Neogen (NEOG) United States $3.541B 37.14
Envista Holdings (NVST) United States $3.248B 17.33
QuidelOrtho (QDEL) United States $3.092B 19.49
Agios Pharmaceuticals (AGIO) United States $2.584B 0.00
Maravai LifeSciences Holdings (MRVI) United States $2.305B 0.00
Green Thumb Industries (GTBIF) United States $2.294B 38.50
LeMaitre Vascular (LMAT) United States $2.022B 53.89
AdaptHealth (AHCO) United States $1.537B 11.10
Warby Parker (WRBY) United States $1.510B 0.00
InMode (INMD) Israel $1.433B 9.12
AtriCure (ATRC) United States $1.329B 0.00
Owens & Minor (OMI) United States $1.237B 9.55
BioLife Solutions (BLFS) United States $1.175B 0.00
Verano Holdings (VRNOF) United States $1.157B 0.00
Evolus (EOLS) United States $1.058B 0.00
PetIQ (PETQ) United States $0.918B 23.28
Phibro Animal Health (PAHC) United States $0.872B 18.09
National Vision Holdings (EYE) United States $0.848B 26.95
Cresco Labs (CRLBF) United States $0.830B 0.00
Surmodics (SRDX) United States $0.563B 119.51
Quanterix (QTRX) United States $0.498B 0.00
VAREX IMAGING (VREX) United States $0.472B 14.23
ZimVie (ZIMV) United States $0.462B 42.95
Valneva SE (VALN) France $0.438B 0.00
Canopy Growth (CGC) Canada $0.418B 0.00
Jin Medical (ZJYL) China $0.394B 0.00
Cerus (CERS) United States $0.382B 0.00
TerrAscend (TSNDF) Canada $0.341B 0.00
OraSure Technologies (OSUR) United States $0.328B 8.46
Aurora Cannabis (ACB) Canada $0.323B 0.00
Biote (BTMD) United States $0.320B 14.77
Sanara MedTech (SMTI) United States $0.294B 0.00
Viemed Healthcare (VMD) United States $0.288B 30.96
Zynex (ZYXI) United States $0.253B 44.28
Ayr Wellness (AYRWF) United States $0.241B 0.00
Utah Medical Products (UTMD) United States $0.234B 15.56
Omeros (OMER) United States $0.226B 0.00
MacroGenics (MGNX) United States $0.215B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.176B 73.00
FitLife Brands (FTLF) United States $0.150B 20.26
Capricor Therapeutics (CAPR) United States $0.144B 0.00
Brainsway (BWAY) Israel $0.141B 168.80
TriSalus Life Sciences (TLSI) United States $0.137B 0.00
Quipt Home Medical (QIPT) United States $0.122B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Veru (VERU) United States $0.119B 0.00
Jushi Holdings (JUSHF) United States $0.110B 0.00
Fonar (FONR) United States $0.109B 11.01
Oramed Pharmaceuticals (ORMP) United States $0.101B 24.80
InterCure (INCR) Israel $0.087B 14.69
Zevia PBC (ZVIA) United States $0.078B 0.00
Cellectar Biosciences (CLRB) United States $0.075B 0.00
Modular Medical (MODD) United States $0.074B 0.00
Safety Shot (SHOT) United States $0.072B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
MariMed (MRMD) United States $0.064B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.055B 3.58
Exagen (XGN) United States $0.051B 0.00
Bright Green (BGXX) United States $0.037B 0.00
Apyx Medical (APYX) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.037B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.027B 0.00
Nephros (NEPH) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Agape ATP (ATPC) $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
United-Guardian (UG) United States $0.000B 21.14
SNDL (SNDL) Canada $0.000B 0.00